JHP Pharmaceuticals Inks Manufacturing Deal

This will be the second multi?year contract JHP has entered during the last two months. JHP will be responsible for the manufacture and supply of an approved therapy used to treat cancer.

JHP Pharmaceuticals has reached a multi‐year contract manufacturing deal with an undisclosed biotechnology company. JHP will be responsible for the manufacture and supply of an approved therapy used to treat cancer.

"We recognize that being selected to produce this crucial drug demonstrates our ability to meet critical marketplace needs. JHP was able to achieve the rigorous timelines required to manufacture this drug through a quality‐driven, experienced staff and a customer‐centric approach. Additionally, our record of cGMP compliance, coupled with our experience in manufacturing site transfers, put us in the position to serve this important customer,” said Stuart Hinchen, president and co‐founder of JHP.

Mr. Hinchen also noted, “This will be the second multi‐year contract JHP has entered during the last two months. These agreements are exa